Qu Biologics Looking for Phase 2 Trial Participants

I want to tell you about Qu Biologics Inc. (Qu), a Canadian biopharmaceutical company developing Site Specific Immunomodulators (SSIs) designed to restore the body’s normal immune function to treat cancer, Crohn's, and other immune-related diseases. Qu is currently conducting their 2nd phase of a new, experimental Crohn's treatment. Instead of suppressing immune function, the process [...]